Peng, Shiwen
Xing, Deyin
Ferrall, Louise
Tsai, Ya-Chea
Hung, Chien-Fu
Wu, T.-C. http://orcid.org/0000-0003-1623-4584
Funding for this research was provided by:
National Cancer Institute (R01CA237067, R50 CA251953-02, P50CA098252)
Article History
Received: 15 February 2022
Accepted: 28 September 2022
First Online: 12 October 2022
Declarations
:
: Not applicable.
: Not applicable.
: T.-C. Wu is a cofounders of and has an equity ownership interest in Papivax LLC. Also, he owns Papivax Biotech, Inc., stock and is a member of the Scientific Advisory Board of Papivax Biotech, Inc<b>.</b> No other author declares a competing interest.